Abstract
The aim of the present study was to compare the contribution of the labelled tracers [C-11]methionine (Met) and [F-18]-fluorodeoxyglucose (FDG) in positron emission tomography (PET)-guided stereotactic biopsy of non resectable brain lesions. Twenty-five patients underwent combined Met-PET-, FDG-PET- and computerized tomography (CT)- or magnetic resonance (MR)-guided stereotactic biopsy according to a previously described technique for stereotactic FDG-PET. Met-PET and FDG-PET images were analyzed to determine which tracer offers the best information to guide at least one stereotactic biopsy trajectory. Histological diagnosis was obtained in all patients (23 tumours and 2 non-tumorous lesions). All tumours had an area of abnormal Met uptake and were biopsied under PET-guidance. FDG uptake in the tumour was higher than in the grey matter and was used for target selection in 12 of 23 tumours. Eleven of them were located in the basal ganglia or the brainstem. Met was used for target selection in 11 of 23 tumours where there was no FDG uptake or where FDG uptake was equivalent to that of the grey matter. Ten of them were located in the cortex. Two nontumoral lesions had no Met uptake and were biopsied under CT- or MR-guidance only. Forty-three out of 53 stereotactic trajectories obtained in these 25 patients were based on PET-defined targets and had an area of abnormal Met uptake. These trajectories always yielded a diagnosis of tumour. Moreover, all tumorous trajectories had an area of abnormal Met uptake. Finally, all non-diagnostic trajectories (n = 4) were CT/MR-defined because there was no area of abnormal Met uptake. These results suggest that patients who can benefit the most from Met-PET guidance could be selected preoperatively. In conclusion, this work shows that Met is a good alternative to FDG for target selection in PET-guided stereotactic brain biopsy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alavi J, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M (1988) Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074–1078
Bergstrom M, Ericson K, Hagenfeldt L, et al (1987) PET study of methionine accumulation in glioma and normal brain tissue: competition with branched chain amino acids. J Comput Assist Tomogr 11:208–213
Black PM (1991) Brain tumors (Second of two parts). N Engl J Med 324: 1555–1564
Chandrasoma PT, Smith MM, Apuzzo MLJ (1989) Stereotactic biopsy in the diagnosis of brain masses: Comparison of results of biopsy and resected surgical specimen. Neurosurgery 24: 160–165
Choksey MS, Valentine A, Shawdon H, Freer CER, Lindsay KD (1989) Computed tomography in the diagnosis of malignant brain tumours: Do all patients requires biopsy? J Neurol Neurosurg Psychiatry 52: 821–825
Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC (1991) Clinical application of PET for the evaluation of brain tumors. J Nucl Med 32: 616–622
Derlon JM, Bourdet C, Bustany P, et al [11C]L-methionine uptake in gliomas (1989) Neurosurgery 25: 720–728
Di Chiro G (1986) Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 22: 360–371
Ericson K, Lilja A, Bergstrom M, et al (1985) Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 9: 683–689
Feiden W, Steude U, Bise K, Gündisch O (1991) Accuracy of stereotactic brain tumor biopsy: Comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev 14: 51–56
Glantz MJ, Burger PC, Herndon II JE, Friedman AH, Cairncross JG, Vick NA, Schold Jr SC (1991) Influence of the type of surgery on the histological diagnosis in patients with anaplastic gliomas. Neurology 41: 1741–1744
Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon II JE, Meisler WJ, Schold Jr SC (1991) Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol 29: 347–355
Goldman S, Levivier M, Pirotte B, Brucher J-M, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J (1996) Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78: 1098–1106
Goldman S, Levivier M, Pirotte B, Brucher J.-M, Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J (1996) Regional methionine and glucose uptake in high grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med, in press
Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ (1987) Imaging-based stereotactic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66: 865–874
Levivier M, Goldman S, Bidaut LM, Luxen A, Stanus E, Przedborski S, Balériaux D, Hildebrand J, Brotchi J (1992) Positron emission tomography-guided stereotactic brain biopsy. Neurosurgery 31: 792–797
Levivier M, Goldman S, Pirotte B, Brucher JM, Balériaux D, Luxen A, Hildebrand J, Brotchi J (1995) Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg 82: 445–452
Mineura K, Sasajima T, Kowada M, Uesaka Y, Shishido F (1991) Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography. J Nucl Med 32: 726–728
Mosskin M, von Holst H, Bergström M, Collins VP, Eriksson L, Johnström P, Norén G (1987) Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 28: 673–681
Ogawa T, Shishido F, Kanno I, et al (1993) Cerebral glioma — evaluation with methionine PET. Radiology 186: 45–53
Patronas NJ, Di-Chiro G, Kufta C, et al (1985) Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816–822
Salmon I, Rorive S, Camby I, Decaestecker Ch, Pirotte B, Rombaut K, Haot J, Pasteels JL, Brotchi J, Kiss R (1995) Stereotactic biopsies from astrocytic tumors — Diagnostic information contributed by the quantitative chromatin pattern description. Analyt Quant Cytol Histol 17: 332–343
Salmon I, Levivier M, Camby I, Rombaut K, Gras T, Pasteels JL, Brotchi J, Kiss R (1993) Assessment of nuclear size, nuclear DNA content and proliferation index in stereotactic biopsies from brain tumours. Neuropathol Appl Neurobiol 19: 507–518
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1997 Springer-Verlag Wien
About this paper
Cite this paper
Pirotte, B. et al. (1997). Stereotactic Brain Biopsy Guided by Positron Emission Tomography (PET) with [F-18]Fluorodeoxyglucose and [C-11]Methionine. In: Ostertag, C.B., Thomas, D.G.T., Bosch, A., Linderoth, B., Broggi, G. (eds) Advances in Stereotactic and Functional Neurosurgery 12. Acta Neurochirurgica Supplements, vol 68. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6513-3_25
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6513-3_25
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7341-1
Online ISBN: 978-3-7091-6513-3
eBook Packages: Springer Book Archive